{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T20:05:46Z","timestamp":1793563546434,"version":"4.5.0"},"reference-count":252,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":427,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1124\/jpet.123.001651","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T13:45:30Z","timestamp":1694094330000},"page":"150-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Hydrocodone, Oxycodone, and Morphine Metabolism and Drug\u2013Drug Interactions"],"prefix":"10.1016","volume":"387","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3887-9298","authenticated-orcid":false,"given":"Shelby","family":"Coates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8686-0874","authenticated-orcid":false,"given":"Philip","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.123.001651_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00126839-200506020-00004","article-title":"Single- and multiple-dose pharmacokinetic and dose-proportionality study of oxymorphone immediate-release tablets","volume":"6","author":"Adams","year":"2005","journal-title":"Drugs R D"},{"key":"10.1124\/jpet.123.001651_bib2","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00520-014-2435-5","article-title":"Long-term safety and efficacy of oxycodone\/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain","volume":"23","author":"Ahmedzai","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1124\/jpet.123.001651_bib3","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1007\/s00520-017-3709-5","article-title":"High dosage of a fixed combination oxycodone\/naloxone prolonged release: efficacy and tolerability in patients with chronic cancer pain","volume":"25","author":"Amato","year":"2017","journal-title":"Support Care Cancer"},{"key":"10.1124\/jpet.123.001651_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0885-3924(02)00531-6","article-title":"Relationships among morphine metabolism, pain and side effects during long-term treatment: an update","volume":"25","author":"Andersen","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1124\/jpet.123.001651_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.71","article-title":"Detection of morphine-3-sulfate and morphine-6-sulfate in human urine and plasma, and formation in liver cytosol","volume":"2","author":"Andersson","year":"2014","journal-title":"Pharmacol Res Perspect"},{"key":"10.1124\/jpet.123.001651_bib6","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.clinthera.2007.06.001","article-title":"Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial","volume":"29","author":"Aqua","year":"2007","journal-title":"Clin Ther"},{"key":"10.1124\/jpet.123.001651_bib7","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1007\/s00213-021-05872-1","article-title":"Relative potency of intravenous oxymorphone compared to other \u00b5 opioid agonists in humans - pilot study outcomes","volume":"238","author":"Babalonis","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.123.001651_bib8","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996-2013","volume":"106","author":"Bachhuber","year":"2016","journal-title":"Am J Public Health"},{"key":"10.1124\/jpet.123.001651_bib9","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/elps.200410301","article-title":"Analysis of oxycodol and noroxycodol stereoisomers in biological samples by capillary electrophoresis","volume":"26","author":"Baldacci","year":"2005","journal-title":"Electrophoresis"},{"key":"10.1124\/jpet.123.001651_bib10","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/elps.200500867","article-title":"Capillary electrophoresis contributions to the hydromorphone metabolism in man","volume":"27","author":"Baldacci","year":"2006","journal-title":"Electrophoresis"},{"key":"10.1124\/jpet.123.001651_bib11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/jat\/bku051","article-title":"Urinary hydrocodone and metabolite distributions in pain patients","volume":"38","author":"Barakat","year":"2014","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.123.001651_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/jat\/bks019","article-title":"Relationship between the concentration of hydrocodone and its conversion to hydromorphone in chronic pain patients using urinary excretion data","volume":"36","author":"Barakat","year":"2012","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.123.001651_bib13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/009127007701700402","article-title":"Comparisons of the analgesic effects of oral and intramuscular oxymorphone and of intramuscular oxymorphone and morphine in patients with cancer","volume":"17","author":"Beaver","year":"1977","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/00498250310001657559","article-title":"Role of individual human cytochrome P450 enzymes in the in vitro metabolism of hydromorphone","volume":"34","author":"Benetton","year":"2004","journal-title":"Xenobiotica"},{"key":"10.1124\/jpet.123.001651_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2165\/00003088-199732030-00004","article-title":"Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions","volume":"32","author":"Bertz","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.123.001651_bib16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/00008571-200011000-00002","article-title":"Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance","volume":"10","author":"Bhasker","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1124\/jpet.123.001651_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-3565(25)20113-6","article-title":"Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat","volume":"278","author":"Bickel","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001651_bib18","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1177\/00185787211061374","article-title":"Drug-Drug Interaction Between Orally Administered Hydrocodone-Acetaminophen and Inhalation of Cannabis Smoke: A Case Report","volume":"57","author":"Bindler","year":"2022","journal-title":"Hosp Pharm"},{"key":"10.1124\/jpet.123.001651_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/pharmacy8010025","article-title":"Preliminary Investigation of Pharmacist-Delivered, Direct-to-Provider Interventions to Reduce Co-Prescribing of Opioids and Benzodiazepines among a Medicare Population","volume":"8","author":"Bingham","year":"2020","journal-title":"Pharmacy (Basel)"},{"key":"10.1124\/jpet.123.001651_bib20","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/nmo.12463","article-title":"Long-term evaluation of combined prolonged-release oxycodone and naloxone in patients with moderate-to-severe chronic pain: pooled analysis of extension phases of two Phase III trials","volume":"26","author":"Blagden","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"10.1124\/jpet.123.001651_bib21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid Prescribing in the United States Before and After the Centers for Disease Control and Prevention\u2019s 2016 Opioid Guideline","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1124\/jpet.123.001651_bib4660508","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/psp4.12619","article-title":"PBPK modeling to predict drug-drug interactions of ivosidenib as a perpetrator in cancer patients and qualification of the Simcyp platform for CYP3A4 induction","volume":"10","author":"Bolleddula","year":"2021","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib22","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.2174\/138161212803582469","article-title":"Non-analgesic effects of opioids: opioid-induced respiratory depression","volume":"18","author":"Boom","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1124\/jpet.123.001651_bib23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/ALN.0b013e318164cf9e","article-title":"Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine","volume":"108","author":"Bostr\u00f6m","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.123.001651_bib24","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/jps.20327","article-title":"Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833","volume":"94","author":"Bostr\u00f6m","year":"2005","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.123.001651_bib25","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1124\/dmd.106.009746","article-title":"In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics\/pharmacodynamics","volume":"34","author":"Bostr\u00f6m","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.123.001651_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1517\/14622416.3.2.229","article-title":"CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants","volume":"3","author":"Bradford","year":"2002","journal-title":"Pharmacogenomics"},{"key":"10.1124\/jpet.123.001651_bib27","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1124\/dmd.109.027706","article-title":"Glucuronidation of the antiretroviral drug efavirenz by UGT2B7 and an in vitro investigation of drug-drug interaction with zidovudine","volume":"37","author":"B\u00e9langer","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.123.001651_bib29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0090-9556(25)07426-4","article-title":"Microsomal codeine N-demethylation: cosegregation with cytochrome P4503A4 activity","volume":"24","author":"Caraco","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.123.001651_bib28","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0022-3565(25)20766-2","article-title":"Pharmacogenetic determination of the effects of codeine and prediction of drug interactions","volume":"278","author":"Caraco","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001651_bib32","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/0024-3205(91)90150-A","article-title":"Mu receptor binding of some commonly used opioids and their metabolites","volume":"48","author":"Chen","year":"1991","journal-title":"Life Sci"},{"key":"10.1124\/jpet.123.001651_bib33","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0090-9556(24)15041-6","article-title":"Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10","volume":"27","author":"Cheng","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.123.001651_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0014-2999(79)90142-0","article-title":"Opiate receptor binding affected differentially by opiates and opioid peptides","volume":"55","author":"Childers","year":"1979","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib2325356","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1210\/jc.2012-2851","article-title":"Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5\u03b1-reductase, explaining the need for personalized glucocorticoid and androgen replacement","volume":"98","author":"Chortis","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.123.001651_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0773.1987.tb01724.x","article-title":"Morphine-6-glucuronide has high affinity for the opioid receptor","volume":"60","author":"Christensen","year":"1987","journal-title":"Pharmacol Toxicol"},{"key":"10.1124\/jpet.123.001651_bib36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1399-6576.1997.tb04625.x","article-title":"Morphine metabolites","volume":"41","author":"Christrup","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1124\/jpet.123.001651_bib37","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/S0022-3565(25)24040-X","article-title":"The influence of pharmacogenetics on opioid analgesia: studies with codeine and oxycodone in the Sprague-Dawley\/Dark Agouti rat model","volume":"271","author":"Cleary","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001651_bib38","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1742-1241.2011.02634.x","article-title":"Bowel function during pain therapy with oxycodone\/naloxone prolonged-release tablets in patients with advanced cancer","volume":"65","author":"Clemens","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.1124\/jpet.123.001651_bib39","first-page":"73","article-title":"The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268)","volume":"26","author":"Coffman","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.123.001651_bib40","first-page":"1","article-title":"Human UGT2B7 catalyzes morphine glucuronidation","volume":"25","author":"Coffman","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.123.001651_bib41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5055\/jom.2008.0021","article-title":"Epidural haloperidol enhances epidural morphine analgesia: three case reports","volume":"4","author":"Colclough","year":"2008","journal-title":"J Opioid Manag"},{"key":"10.1124\/jpet.123.001651_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00228-008-0570-y","article-title":"Role of active metabolites in the use of opioids","volume":"65","author":"Coller","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib43","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/aas.12051","article-title":"A comparison of oxycodone prolonged-release vs. oxycodone + naloxone prolonged-release after laparoscopic hysterectomy","volume":"57","author":"Comelon","year":"2013","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1124\/jpet.123.001651_bib44","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/bms.1200050404","article-title":"Simultaneous determination of hydromorphone, hydrocodone and their 6alpha- and 6beta-hydroxy metabolites in urine using selected ion recording with methane chemical ionization","volume":"5","author":"Cone","year":"1978","journal-title":"Biomed Mass Spectrom"},{"key":"10.1124\/jpet.123.001651_bib45","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0090-9556(25)06378-0","article-title":"Comparative metabolism of hydrocodone in man, rat, guinea pig, rabbit, and dog","volume":"6","author":"Cone","year":"1978","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.123.001651_bib46","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jat\/bkt031","article-title":"Prescription opioids. I. Metabolism and excretion patterns of oxycodone in urine following controlled single dose administration","volume":"37","author":"Cone","year":"2013","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.123.001651_bib47","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/jat\/bkt066","article-title":"Prescription opioids. II. Metabolism and excretion patterns of hydrocodone in urine following controlled single-dose administration","volume":"37","author":"Cone","year":"2013","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.123.001651_bib48","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1177\/1049909113510058","article-title":"Efficacy and gastrointestinal tolerability of oral oxycodone\/naloxone combination for chronic pain in outpatients with cancer: an observational study","volume":"31","author":"Cuomo","year":"2014","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1124\/jpet.123.001651_bib49","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.15585\/mmwr.mm6736a2","article-title":"Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults - United States, 2016","volume":"67","author":"Dahlhamer","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1124\/jpet.123.001651_bib50","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0022-3565(24)29199-0","article-title":"Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos","volume":"299","author":"Dai","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001651_bib51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-200645010-00002","article-title":"Significance of the minor cytochrome P450 3A isoforms","volume":"45","author":"Daly","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.123.001651_bib52","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.clinthera.2014.11.014","article-title":"Single- and multiple-dose pharmacokinetics of a hydrocodone bitartrate extended-release tablet formulated with abuse-deterrence technology in healthy, naltrexone-blocked volunteers","volume":"37","author":"Darwish","year":"2015","journal-title":"Clin Ther"},{"key":"10.1124\/jpet.123.001651_bib53","first-page":"85","article-title":"Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality","volume":"17","author":"Dasgupta","year":"2016","journal-title":"Pain Med"},{"key":"10.1124\/jpet.123.001651_bib54","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.2147\/OTT.S108144","article-title":"Analgesic effectiveness and tolerability of oral oxycodone\/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis","volume":"9","author":"De Santis","year":"2016","journal-title":"OncoTargets Ther"},{"key":"10.1124\/jpet.123.001651_bib55","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/jat\/bkw064","article-title":"Metabolism and Excretion of Oxymorphone in Urine Following Controlled Single Dose Administration Prescription Opioids. V","volume":"40","author":"DePriest","year":"2016","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.123.001651_bib56","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/jat\/bkw066","article-title":"Metabolism and Excretion of Hydromorphone in Urine Following Controlled Single-Dose Administration Prescription Opioids. VI","volume":"40","author":"DePriest","year":"2016","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.123.001651_bib57","series-title":"StatPearls","article-title":"Physiology, Opioid Receptor","author":"Dhaliwal","year":"2023"},{"key":"10.1124\/jpet.123.001651_bib58","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejphar.2010.07.019","article-title":"Effect of metamizol on morphine pharmacokinetics and pharmacodynamics after acute and subchronic administration in arthritic rats","volume":"645","author":"Dom\u00ednguez-Ram\u00edrez","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s005200100274","article-title":"Morphine in cancer pain management: a practical guide","volume":"10","author":"Donnelly","year":"2002","journal-title":"Support Care Cancer"},{"key":"10.1124\/jpet.123.001651_bib60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3959(01)00306-2","article-title":"Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine","volume":"93","author":"Doverty","year":"2001","journal-title":"Pain"},{"key":"10.1124\/jpet.123.001651_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1124\/jpet.123.001651_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"10.1124\/jpet.123.001651_bib63","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2125.2012.04317.x","article-title":"Differences between opioids: pharmacological, experimental, clinical and economical perspectives","volume":"75","author":"Drewes","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2217\/pmt-2017-0065","article-title":"Prescribing naloxone for opioid overdose intervention","volume":"8","author":"Dunne","year":"2018","journal-title":"Pain Manag (Lond)"},{"key":"10.1124\/jpet.123.001651_bib65","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/ejp.1054","article-title":"A phase III randomized controlled study on the efficacy and improved bowel function of prolonged-release (PR) oxycodone-naloxone (up to 160\/80 mg daily) vs oxycodone PR","volume":"21","author":"Dupoiron","year":"2017","journal-title":"Eur J Pain"},{"key":"10.1124\/jpet.123.001651_bib66","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1213\/00000539-200007000-00035","article-title":"Gabapentin enhances the analgesic effect of morphine in healthy volunteers","volume":"91","author":"Eckhardt","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1124\/jpet.123.001651_bib67","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0022-3565(25)12962-5","article-title":"The analgesic equivalence to morphine and relative side action liability of oxymorphone (14-hydroxydihydro morphinone)","volume":"125","author":"Eddy","year":"1959","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001651_bib68","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jat\/bku007","article-title":"Observations of urinary oxycodone and metabolite distributions in pain patients","volume":"38","author":"Elder","year":"2014","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.123.001651_bib69","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/FPC.0b013e32834c6edb","article-title":"Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in the Rotterdam Study","volume":"21","author":"Elens","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.123.001651_bib70","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1373\/clinchem.2011.165613","article-title":"A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipients","volume":"57","author":"Elens","year":"2011","journal-title":"Clin Chem"},{"key":"10.1124\/jpet.123.001651_bib71","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.286.5439.487","article-title":"Pharmacogenomics: translating functional genomics into rational therapeutics","volume":"286","author":"Evans","year":"1999","journal-title":"Science"},{"key":"10.1124\/jpet.123.001651_bib72","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0304-3959(97)00142-5","article-title":"Systematic review of factors affecting the ratios of morphine and its major metabolites","volume":"74","author":"Faura","year":"1998","journal-title":"Pain"},{"key":"10.1124\/jpet.123.001651_bib73","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1090-3801(97)90074-4","article-title":"Morphine-3-glucuronide prevents tolerance to morphine-6-glucuronide in mice","volume":"1","author":"Faura","year":"1997","journal-title":"Eur J Pain"},{"key":"10.1124\/jpet.123.001651_bib74","unstructured":"Food and Drug Administration (FDA) (2017) FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning, in (Services USDoHaH ed). https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-about-serious-risks-and-death-when-combining-opioid-pain-or."},{"key":"10.1124\/jpet.123.001651_bib75","series-title":"In Vitro Drug Interaction Studies - Cytochrome P450 Enzyme - and Transporter-Mediated Drug Interactions Guidance for Industry, in (Services USDoHaH ed)","first-page":"1","year":"2020"},{"key":"10.1124\/jpet.123.001651_bib76","series-title":"Drug Development and Drug Interactions; Table of Substrates, Inhibitors and Inducers","year":"2022"},{"key":"10.1124\/jpet.123.001651_bib77","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00000542-199708000-00019","article-title":"Isobolographic analysis of interactions between intravenous morphine, propacetamol, and diclofenac in carrageenin-injected rats","volume":"87","author":"Fletcher","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.123.001651_bib78","series-title":"The Flockhart Cytochrome P450 Drug-Drug Interaction Table.","author":"Flockhart","year":"2021"},{"key":"10.1124\/jpet.123.001651_bib79","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-3565(25)10743-X","article-title":"Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine","volume":"262","author":"Frances","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001651_bib80","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0304-3959(97)00044-4","article-title":"Loss of analgesic effect of morphine due to coadministration of rifampin","volume":"72","author":"Fromm","year":"1997","journal-title":"Pain"},{"key":"10.1124\/jpet.123.001651_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104215","article-title":"Effects of aprepitant on the pharmacokinetics of controlled-release oral oxycodone in cancer patients","volume":"9","author":"Fujiwara","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/jpet.123.001651_bib82","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/cpt.2321","article-title":"Pharmacogene Variation Consortium: A Global Resource and Repository for Pharmacogene Variation","volume":"110","author":"Gaedigk","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.123.001651_bib83","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/cpt.910","article-title":"The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database","volume":"103","author":"Gaedigk","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.123.001651_bib84","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/cpt.1654","article-title":"PharmVar and the Landscape of Pharmacogenetic Resources","volume":"107","author":"Gaedigk","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.123.001651_bib85","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0009-9236(03)00237-6","article-title":"Cytochrome p450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: correlation with alprazolam pharmacokinetics","volume":"74","author":"Gashaw","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.123.001651_bib86","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1365-2125.2011.04145.x","article-title":"Methadone inhibits CYP2D6 and UGT2B7\/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjects","volume":"73","author":"Gelston","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib87","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1213\/01.ANE.0000132548.91622.B3","article-title":"The efficacy and safety of oral immediate-release oxymorphone for postsurgical pain","volume":"99","author":"Gimbel","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1124\/jpet.123.001651_bib88","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.apmr.2005.07.303","article-title":"Efficacy and safety of oxymorphone immediate release for the treatment of mild to moderate pain after ambulatory orthopedic surgery: results of a randomized, double-blind, placebo-controlled trial","volume":"86","author":"Gimbel","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1124\/jpet.123.001651_bib89","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2125.2004.02265.x","article-title":"Influence of rifampicin on the expression and function of human intestinal cytochrome P450 enzymes","volume":"59","author":"Glaeser","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib90","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/dna.1988.7.79","article-title":"Human P450PCN1: sequence, chromosome localization, and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase","volume":"7","author":"Gonzalez","year":"1988","journal-title":"DNA"},{"key":"10.1124\/jpet.123.001651_bib91","first-page":"507","article-title":"Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3","volume":"26","author":"Green","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.123.001651_bib95","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2125.2010.03653.x","article-title":"Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone","volume":"70","author":"Gr\u00f6nlund","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib92","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/0091270009336444","article-title":"Effect of telithromycin on the pharmacokinetics and pharmacodynamics of oral oxycodone","volume":"50","author":"Gr\u00f6nlund","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib94","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/11539950-000000000-00000","article-title":"Effect of inhibition of cytochrome P450 enzymes 2D6 and 3A4 on the pharmacokinetics of intravenous oxycodone: a randomized, three-phase, crossover, placebo-controlled study","volume":"31","author":"Gr\u00f6nlund","year":"2011","journal-title":"Clin Drug Investig"},{"key":"10.1124\/jpet.123.001651_bib93","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1128\/AAC.01242-10","article-title":"Miconazole oral gel increases exposure to oral oxycodone by inhibition of CYP2D6 and CYP3A4","volume":"55","author":"Gr\u00f6nlund","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.123.001651_bib96","series-title":"Cytochrome P450: Structure, Mechanism, and Biochemistry","first-page":"377","article-title":"Human cytochrome P450 enzymes","author":"Guengerich","year":"2005"},{"key":"10.1124\/jpet.123.001651_bib97","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00228-008-0568-5","article-title":"Voriconazole drastically increases exposure to oral oxycodone","volume":"65","author":"Hagelberg","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib98","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/j.1552-4604.1995.tb04743.x","article-title":"Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphone","volume":"35","author":"Hagen","year":"1995","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib99","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jpain.2004.09.005","article-title":"Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study","volume":"6","author":"Hale","year":"2005","journal-title":"J Pain"},{"key":"10.1124\/jpet.123.001651_bib100","first-page":"1","article-title":"Prevalence of Prescription Pain Medication Use Among Adults: United States, 2015-2018","author":"Hales","year":"2020","journal-title":"NCHS Data Brief"},{"key":"10.1124\/jpet.123.001651_bib101","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/bja\/64.5.547","article-title":"Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine","volume":"64","author":"Hanna","year":"1990","journal-title":"Br J Anaesth"},{"key":"10.1124\/jpet.123.001651_bib102","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10337-011-2118-z","article-title":"Simultaneous Determination of Hydrocodone, and Its Two Metabolites in Human Plasma by HPLC\u2013MS\u2013MS","volume":"74","author":"Hao","year":"2011","journal-title":"Chromatographia"},{"key":"10.1124\/jpet.123.001651_bib103","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2133\/dmpk.22.103","article-title":"Morphine glucuronosyltransferase activity in human liver microsomes is inhibited by a variety of drugs that are co-administered with morphine","volume":"22","author":"Hara","year":"2007","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/jpet.123.001651_bib104","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2165\/00003088-199324040-00007","article-title":"Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations","volume":"24","author":"Hasselstr\u00f6m","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.123.001651_bib105","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0009-9236(98)90051-0","article-title":"Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone","volume":"64","author":"Heiskanen","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.123.001651_bib106","first-page":"877","article-title":"Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids","volume":"38","author":"Hennies","year":"1988","journal-title":"Arzneimittelforschung"},{"issue":"Suppl","key":"10.1124\/jpet.123.001651_bib107","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.clinthera.2007.12.003","article-title":"Adverse drug interactions involving common prescription and over-the-counter analgesic agents","volume":"29","author":"Hersh","year":"2007","journal-title":"Clin Ther"},{"key":"10.1124\/jpet.123.001651_bib108","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/14656566.2015.1001737","article-title":"Prolonged-release oxycodone\/naloxone in opioid-na\u00efve patients - subgroup analysis of a prospective observational study","volume":"16","author":"Hesselbarth","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1124\/jpet.123.001651_bib109","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3109\/00498254.2015.1038743","article-title":"In vitro glucuronidation of aprepitant: a moderate inhibitor of UGT2B7","volume":"45","author":"House","year":"2015","journal-title":"Xenobiotica"},{"key":"10.1124\/jpet.123.001651_bib110","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/FPC.0000000000000351","article-title":"PharmGKB summary: oxycodone pathway, pharmacokinetics","volume":"28","author":"Huddart","year":"2018","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.123.001651_bib111","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2125.2003.02002.x","article-title":"CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes","volume":"57","author":"Hutchinson","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib112","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amepre.2016.02.014","article-title":"Trends in the Concomitant Prescribing of Opioids and Benzodiazepines, 2002-2014","volume":"51","author":"Hwang","year":"2016","journal-title":"Am J Prev Med"},{"key":"10.1124\/jpet.123.001651_bib113","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1742-7843.2011.00814.x","article-title":"Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. a minireview","volume":"110","author":"Ing Lorenzini","year":"2012","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/jpet.123.001651_bib114","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.tpj.6500285","article-title":"Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity","volume":"5","author":"Ingelman-Sundberg","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/jpet.123.001651_bib115","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1098\/rstb.2005.1685","article-title":"Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy","volume":"360","author":"Ingelman-Sundberg","year":"2005","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1124\/jpet.123.001651_bib116","series-title":"Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research.","year":"2011"},{"issue":"4, Suppl","key":"10.1124\/jpet.123.001651_bib117","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00002508-200207001-00002","article-title":"Clinical pharmacology of opioids for pain","volume":"18","author":"Inturrisi","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1124\/jpet.123.001651_bib118","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1248\/bpb.b12-00568","article-title":"Inhibition of morphine glucuronidation in the liver microsomes of rats and humans by monoterpenoid alcohols","volume":"35","author":"Ishii","year":"2012","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/jpet.123.001651_bib119","series-title":"The Pharmacological Basis of Therapuetics","first-page":"497","article-title":"Opioid Analgesics and Antagonists","author":"Jaffe","year":"1990"},{"key":"10.1124\/jpet.123.001651_bib120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jflm.2008.08.002","article-title":"Prevalence of dihydrocodeine in hydrocodone positive postmortem specimens","volume":"16","author":"Jenkins","year":"2009","journal-title":"J Forensic Leg Med"},{"key":"10.1124\/jpet.123.001651_bib121","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jpain.2010.07.002","article-title":"The prevalence of chronic pain in United States adults: results of an Internet-based survey","volume":"11","author":"Johannes","year":"2010","journal-title":"J Pain"},{"key":"10.1124\/jpet.123.001651_bib122","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: a review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.123.001651_bib123","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0009-9236(96)90024-7","article-title":"Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone","volume":"59","author":"Kaiko","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.123.001651_bib124","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1055\/s-0034-1396682","article-title":"Controlled-Release Oxycodone as \u201cGold Standard\u201d for Postoperative Pain Therapy in Patients Undergoing Video-Assisted Thoracic Surgery or Thoracoscopy: A Retrospective Evaluation of 788 Cases","volume":"63","author":"Kampe","year":"2015","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1124\/jpet.123.001651_bib125","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/clpt.2008.215","article-title":"The CYP3A4*18 genotype in the cytochrome P450 3A4 gene, a rapid metabolizer of sex steroids, is associated with low bone mineral density","volume":"85","author":"Kang","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.123.001651_bib126","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.clinthera.2015.08.007","article-title":"Effects of paroxetine, a CYP2D6 inhibitor, on the pharmacokinetic properties of hydrocodone after coadministration with a single-entity, once-daily, extended-release hydrocodone tablet","volume":"37","author":"Kapil","year":"2015","journal-title":"Clin Ther"},{"key":"10.1124\/jpet.123.001651_bib127","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0022-3565(24)36599-1","article-title":"Inhibition of cytochrome P450 2D6 metabolism of hydrocodone to hydromorphone does not importantly affect abuse liability","volume":"281","author":"Kaplan","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001651_bib128","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/med.20035","article-title":"Morphine-6-glucuronide: actions and mechanisms","volume":"25","author":"Kilpatrick","year":"2005","journal-title":"Med Res Rev"},{"key":"10.1124\/jpet.123.001651_bib129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/toxsci\/61.1.49","article-title":"Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac","volume":"61","author":"King","year":"2001","journal-title":"Toxicol Sci"},{"key":"10.1124\/jpet.123.001651_bib130","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s002280050003","article-title":"Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine","volume":"55","author":"Klepstad","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib131","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0022-2275(20)30141-3","article-title":"Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor","volume":"43","author":"Kliewer","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.123.001651_bib132","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1213\/01.ANE.0000087801.20395.97","article-title":"The synergistic analgesic interactions between hydrocodone and ibuprofen","volume":"97","author":"Kolesnikov","year":"2003","journal-title":"Anesth Analg"},{"key":"10.1124\/jpet.123.001651_bib133","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00228-010-0893-3","article-title":"Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone","volume":"67","author":"Kummer","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib134","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejps.2014.05.003","article-title":"Sulfation of opioid drugs by human cytosolic sulfotransferases: metabolic labeling study and enzymatic analysis","volume":"62","author":"Kurogi","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/jpet.123.001651_bib135","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.clpt.2006.01.009","article-title":"Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites","volume":"79","author":"Lalovic","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.123.001651_bib136","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1124\/dmd.32.4.447","article-title":"Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes","volume":"32","author":"Lalovic","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.123.001651_bib137","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/phar.2385","article-title":"Comparison of Hydromorphone versus Fentanyl-based Sedation in Extracorporeal Membrane Oxygenation: A Propensity-Matched Analysis","volume":"40","author":"Landolf","year":"2020","journal-title":"Pharmacotherapy"},{"key":"10.1124\/jpet.123.001651_bib138","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/FTD.0b013e318283e29a","article-title":"Therapeutic monitoring of opioids: a sensitive LC-MS\/MS method for quantitation of several opioids including hydrocodone and its metabolites","volume":"35","author":"Langman","year":"2013","journal-title":"Ther Drug Monit"},{"key":"10.1124\/jpet.123.001651_bib139","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/03009742.2016.1218543","article-title":"Chronic pain in older adults: prevalence, incidence, and risk factors","volume":"46","author":"Larsson","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"10.1124\/jpet.123.001651_bib140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.toxlet.2017.11.038","article-title":"Effect of UGT2B7*2 and CYP2C8*4 polymorphisms on diclofenac metabolism","volume":"284","author":"Lazarska","year":"2018","journal-title":"Toxicol Lett"},{"key":"10.1124\/jpet.123.001651_bib141","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.2147\/DDDT.S92998","article-title":"Efficacy and tolerability of oral oxycodone and oxycodone\/naloxone combination in opioid-na\u00efve cancer patients: a propensity analysis","volume":"9","author":"Lazzari","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1124\/jpet.123.001651_bib142","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cca.2005.11.030","article-title":"Negative urine opioid screening caused by rifampin-mediated induction of oxycodone hepatic metabolism","volume":"367","author":"Lee","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1124\/jpet.123.001651_bib143","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.sjpain.2009.09.003","article-title":"Does co-administration of paroxetine change oxycodone analgesia: An interaction study in chronic pain patients","volume":"1","author":"Lemberg","year":"2010","journal-title":"Scand J Pain"},{"key":"10.1124\/jpet.123.001651_bib144","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/FBP.0000000000000542","article-title":"Effects of oxycodone and diazepam alone and in combination on operant nociception","volume":"31","author":"Leonard","year":"2020","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib145","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/0024-3205(94)00849-3","article-title":"The antinociceptive potencies of oxycodone, noroxycodone and morphine after intracerebroventricular administration to rats","volume":"54","author":"Leow","year":"1994","journal-title":"Life Sci"},{"key":"10.1124\/jpet.123.001651_bib146","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/bph.12974","article-title":"Ketamine coadministration attenuates morphine tolerance and leads to increased brain concentrations of both drugs in the rat","volume":"172","author":"Lilius","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib147","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/JCP.0b013e3182189892","article-title":"Inhibition of cytochrome P450 3A by clarithromycin uniformly affects the pharmacokinetics and pharmacodynamics of oxycodone in young and elderly volunteers","volume":"31","author":"Liukas","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/jpet.123.001651_bib148","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0014-2999(94)90802-8","article-title":"Mechanisms of the influence of midazolam on morphine antinociception at spinal and supraspinal levels in rats","volume":"271","author":"Luger","year":"1994","journal-title":"Eur J Pharmacol"},{"issue":"5, Suppl","key":"10.1124\/jpet.123.001651_bib149","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jpainsymman.2005.01.004","article-title":"Opioid metabolites","volume":"29","author":"L\u00f6tsch","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.1124\/jpet.123.001651_bib150","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0009-9236(96)90058-2","article-title":"Pharmacokinetics of morphine and its glucuronides after intravenous infusion of morphine and morphine-6-glucuronide in healthy volunteers","volume":"60","author":"L\u00f6tsch","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.123.001651_bib151","doi-asserted-by":"crossref","first-page":"e986","DOI":"10.1542\/peds.2009-1907","article-title":"Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions","volume":"126","author":"Madadi","year":"2010","journal-title":"Pediatrics"},{"key":"10.1124\/jpet.123.001651_bib152","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2217\/14622416.9.9.1267","article-title":"Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use","volume":"9","author":"Madadi","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1124\/jpet.123.001651_bib153","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2125.1988.tb03338.x","article-title":"The effect of metoclopramide on the absorption of oral controlled release morphine","volume":"25","author":"Manara","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib7412445","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/jac\/dkw032","article-title":"Cobicistat versus ritonavir boosting and differences in the drug-drug interaction profiles with co-medications","volume":"71","author":"Marzolini","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1124\/jpet.123.001651_bib154","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1002\/phar.1581","article-title":"Serotonin syndrome probably triggered by a morphine-phenelzine interaction","volume":"35","author":"Mateo-Carrasco","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1124\/jpet.123.001651_bib155","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3390\/pharmacy8030154","article-title":"Opioids, Polypharmacy, and Drug Interactions: A Technological Paradigm Shift Is Needed to Ameliorate the Ongoing Opioid Epidemic","volume":"8","author":"Matos","year":"2020","journal-title":"Pharmacy (Basel)"},{"key":"10.1124\/jpet.123.001651_bib156","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0167-4889(02)00345-2","article-title":"Taurine modulates induction of cytochrome P450 3A4 mRNA by rifampicin in the HepG2 cell line","volume":"1593","author":"Matsuda","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.123.001651_bib157","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1081\/CLT-120026516","article-title":"Do co-intoxicants increase adverse event rates in the first 24 hours in patients resuscitated from acute opioid overdose?","volume":"41","author":"Mirakbari","year":"2003","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1124\/jpet.123.001651_bib158","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/bcpt.12999","article-title":"Inhibition of In Vitro Metabolism of Opioids by Skeletal Muscle Relaxants","volume":"123","author":"Moody","year":"2018","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/jpet.123.001651_bib159","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/jat\/27.6.346","article-title":"Tentative identification of novel oxycodone metabolites in human urine","volume":"27","author":"Moore","year":"2003","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.123.001651_bib182776722","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s00228-013-1556-y","article-title":"A randomised study of the effect of danoprevir\/ritonavir or ritonavir on substrates of cytochrome P450 (CYP) 3A and 2C9 in chronic hepatitis C patients using a drug cocktail","volume":"69","author":"Morcos","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib160","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2125.2005.02573.x","article-title":"Differential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioids","volume":"61","author":"Morrish","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib161","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1177\/0091270010388033","article-title":"CYP3A5*3 affects plasma disposition of noroxycodone and dose escalation in cancer patients receiving oxycodone","volume":"51","author":"Naito","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib162","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2133\/dmpk.24.490","article-title":"Inhibitory effects of Kampo medicine on human UGT2B7 activity","volume":"24","author":"Nakagawa","year":"2009","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/jpet.123.001651_bib166","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1742-7843.2010.00582.x","article-title":"Grapefruit juice enhances the exposure to oral oxycodone","volume":"107","author":"Nieminen","year":"2010","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/jpet.123.001651_bib167","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00228-010-0879-1","article-title":"Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir\/ritonavir","volume":"66","author":"Nieminen","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib165","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ejpain.2009.12.007","article-title":"St John\u2019s wort greatly reduces the concentrations of oral oxycodone","volume":"14","author":"Nieminen","year":"2010","journal-title":"Eur J Pain"},{"key":"10.1124\/jpet.123.001651_bib168","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/ALN.0b013e31819faa54","article-title":"Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone","volume":"110","author":"Nieminen","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.123.001651_bib169","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/cpt.1434","article-title":"Pharmacodynamic Drug-Drug Interactions","volume":"105","author":"Niu","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.123.001651_bib170","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/0024-3205(87)90710-7","article-title":"Enhanced binding of morphine and nalorphine to opioid delta receptor by glucuronate and sulfate conjugations at the 6-position","volume":"41","author":"Oguri","year":"1987","journal-title":"Life Sci"},{"key":"10.1124\/jpet.123.001651_bib171","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1124\/dmd.107.019281","article-title":"Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties","volume":"36","author":"Ohno","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.123.001651_bib172","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1124\/dmd.108.022087","article-title":"Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone","volume":"36","author":"Okura","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.123.001651_bib173","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/ALN.0b013e3181d5e29d","article-title":"Naloxone reversal of morphine- and morphine-6-glucuronide-induced respiratory depression in healthy volunteers: a mechanism-based pharmacokinetic-pharmacodynamic modeling study","volume":"112","author":"Olofsen","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.123.001651_bib174","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/clpt.1990.2","article-title":"Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide","volume":"47","author":"Osborne","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.123.001651_bib175","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2125.1992.tb04121.x","article-title":"The analgesic activity of morphine-6-glucuronide","volume":"34","author":"Osborne","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib176","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/clpt.1993.177","article-title":"CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone","volume":"54","author":"Otton","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.123.001651_bib10988297","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/clpt.1993.43","article-title":"Inhibition by fluoxetine of cytochrome P450 2D6 activity","volume":"53","author":"Otton","year":"1993","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 11","key":"10.1124\/jpet.123.001651_bib177","first-page":"S276","article-title":"Opioid pharmacokinetic drug-drug interactions","volume":"17","author":"Overholser","year":"2011","journal-title":"Am J Manag Care"},{"key":"10.1124\/jpet.123.001651_bib178","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s002280050368","article-title":"Polymorphic CYP2D6 mediates O-demethylation of the opioid analgesic tramadol","volume":"53","author":"Paar","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib179","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1520\/JFS11471J","article-title":"Hydromorphone detected in bile following hydrocodone ingestion","volume":"27","author":"Park","year":"1982","journal-title":"J Forensic Sci"},{"key":"10.1124\/jpet.123.001651_bib180","doi-asserted-by":"crossref","first-page":"h2698","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"BMJ"},{"key":"10.1124\/jpet.123.001651_bib181","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/0024-3205(87)90431-0","article-title":"Morphine-6-glucuronide, a potent mu agonist","volume":"41","author":"Pasternak","year":"1987","journal-title":"Life Sci"},{"key":"10.1124\/jpet.123.001651_bib2447208","first-page":"501","article-title":"Apalutamide for the Treatment of Nonmetastatic Castration-Resistant Prostate Cancer","volume":"10","author":"Patel","year":"2019","journal-title":"J Adv Pract Oncol"},{"key":"10.1124\/jpet.123.001651_bib182","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0022-3565(25)20832-1","article-title":"Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite","volume":"251","author":"Paul","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001651_bib183","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2125.2002.01554.x","article-title":"The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide","volume":"53","author":"Penson","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib184","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0361-9230(96)00265-1","article-title":"Antinociceptive interaction between alprazolam and opioids","volume":"42","author":"Pick","year":"1997","journal-title":"Brain Res Bull"},{"key":"10.1124\/jpet.123.001651_bib185","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s40262-016-0373-8","article-title":"Drug\u2013Drug Interactions Between the Anti-Hepatitis C Virus 3D Regimen of Ombitasvir, Paritaprevir\/Ritonavir, and Dasabuvir and Eight Commonly Used Medications in Healthy Volunteers","volume":"55","author":"Polepally","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.123.001651_bib186","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/clpt.1992.42","article-title":"The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function","volume":"51","author":"Portenoy","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.123.001651_bib187","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/0049825031000121608","article-title":"Identification of CYP3A4 and CYP2C8 as the major cytochrome P450 s responsible for morphine N-demethylation in human liver microsomes","volume":"33","author":"Projean","year":"2003","journal-title":"Xenobiotica"},{"key":"10.1124\/jpet.123.001651_bib188","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fnagi.2016.00144","article-title":"Pharmacotherapy of Pain in the Older Population: The Place of Opioids","volume":"8","author":"Prostran","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"10.1124\/jpet.123.001651_bib189","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3389\/fphar.2018.01145","article-title":"Drug Interactions With New Synthetic Opioids","volume":"9","author":"P\u00e9rez-Ma\u00f1\u00e1","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0885-3924(93)90101-Z","article-title":"A review of oxycodone\u2019s clinical pharmacokinetics and pharmacodynamics","volume":"8","author":"P\u00f6yhi\u00e4","year":"1993","journal-title":"J Pain Symptom Manage"},{"key":"10.1124\/jpet.123.001651_bib191","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0304-3959(92)90065-J","article-title":"Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat","volume":"48","author":"Qian-Ling","year":"1992","journal-title":"Pain"},{"key":"10.1124\/jpet.123.001651_bib192","doi-asserted-by":"crossref","first-page":"295","DOI":"10.7326\/M14-2775","article-title":"National Institutes of Health Pathways to Prevention Workshop: the role of opioids in the treatment of chronic pain","volume":"162","author":"Reuben","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1124\/jpet.123.001651_bib193","first-page":"623","article-title":"Oxidative metabolism of clarithromycin in the presence of human liver microsomes. Major role for the cytochrome P4503A (CYP3A) subfamily","volume":"25","author":"Rodrigues","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.123.001651_bib194","doi-asserted-by":"crossref","first-page":"10406","DOI":"10.1038\/s41598-017-11120-4","article-title":"Morphine-induced hyperalgesia involves mu opioid receptors and the metabolite morphine-3-glucuronide","volume":"7","author":"Roeckel","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.123.001651_bib195","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jpba.2016.09.024","article-title":"Characterization of oxycodone in vitro metabolism by human cytochromes P450 and UDP-glucuronosyltransferases","volume":"144","author":"Romand","year":"2017","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/jpet.123.001651_bib196","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00228-009-0775-8","article-title":"Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone","volume":"66","author":"Saari","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib197","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.12659\/AJCR.905637","article-title":"Oxycodone Resistance Due to Rifampin Use in an Osteosarcoma Patient with Tuberculosis","volume":"18","author":"Sakamoto","year":"2017","journal-title":"Am J Case Rep"},{"issue":"Suppl 196","key":"10.1124\/jpet.123.001651_bib198","first-page":"196","article-title":"Serotoninergic neurotransmission and morphine activity","volume":"196","author":"Samanin","year":"1972","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1124\/jpet.123.001651_bib199","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1476-5381.2010.00673.x","article-title":"The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone","volume":"160","author":"Samer","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib200","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1476-5381.2010.00709.x","article-title":"Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety","volume":"160","author":"Samer","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib201","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12987-017-0080-3","article-title":"The opioid epidemic: a central role for the blood brain barrier in opioid analgesia and abuse","volume":"14","author":"Schaefer","year":"2017","journal-title":"Fluids Barriers CNS"},{"key":"10.1124\/jpet.123.001651_bib693874","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/1872312812666180328105259","article-title":"Cytochrome P450 3A4 Induction: Lumacaftor versus Ivacaftor Potentially Resulting in Significantly Reduced Plasma Concentration of Ivacaftor","volume":"12","author":"Schneider","year":"2018","journal-title":"Drug Metab Lett"},{"key":"10.1124\/jpet.123.001651_bib202","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1007\/s00213-014-3490-9","article-title":"Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties","volume":"231","author":"Seleman","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.123.001651_bib203","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1124\/dmd.114.061093","article-title":"Inflammation-induced phenoconversion of polymorphic drug metabolizing enzymes: hypothesis with implications for personalized medicine","volume":"43","author":"Shah","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.123.001651_bib204","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1067\/mjd.2002.126823","article-title":"Drug interactions: Proteins, pumps, and P-450s","volume":"47","author":"Shapiro","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1124\/jpet.123.001651_bib205","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.gene.2019.05.025","article-title":"Associations between UGT2B7 polymorphisms and cancer susceptibility: A meta-analysis","volume":"706","author":"Shen","year":"2019","journal-title":"Gene"},{"key":"10.1124\/jpet.123.001651_bib206","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1620\/tjem.105.45","article-title":"Analgesic effect of morphine glucuronides","volume":"105","author":"Shimomura","year":"1971","journal-title":"Tohoku J Exp Med"},{"key":"10.1124\/jpet.123.001651_bib207","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","article-title":"Opioid metabolism","volume":"84","author":"Smith","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1124\/jpet.123.001651_bib208","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00000542-200401000-00022","article-title":"Effects of perioperative oral amantadine on postoperative pain and morphine consumption in patients after radical prostatectomy: results of a preliminary study","volume":"100","author":"Snijdelaar","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.123.001651_bib209","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060239","article-title":"CYP2D6 genotype dependent oxycodone metabolism in postoperative patients","volume":"8","author":"Stamer","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/jpet.123.001651_bib210","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pharmthera.2013.09.002","article-title":"Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review","volume":"141","author":"Stingl","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.123.001651_bib211","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1124\/dmd.31.9.1086","article-title":"Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human udp-glucuronosyltransferases: evidence for atypical glucuronidation kinetics by UGT2B7","volume":"31","author":"Stone","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.123.001651_bib212","first-page":"1146","article-title":"Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes","volume":"29","author":"Subrahmanyam","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.123.001651_bib213","doi-asserted-by":"crossref","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"},{"key":"10.1124\/jpet.123.001651_bib214","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1124\/dmd.106.009738","article-title":"Inhibition of UDP-glucuronosyltransferase 2b7-catalyzed morphine glucuronidation by ketoconazole: dual mechanisms involving a novel noncompetitive mode","volume":"34","author":"Takeda","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.123.001651_bib215","series-title":"Opioid Antagonists","author":"Theriot","year":"2023"},{"key":"10.1124\/jpet.123.001651_bib216","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1158\/0008-5472.CAN-05-2857","article-title":"Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone","volume":"66","author":"Thibaudeau","year":"2006","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.123.001651_bib217","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/jpet.103.058602","article-title":"Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O- and N-demethylated metabolites at mu- and delta-opioid receptors","volume":"308","author":"Thompson","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001651_bib218","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1213\/00000539-199905000-00032","article-title":"Persistently high plasma morphine-6-glucuronide levels despite decreased hourly patient-controlled analgesia morphine use after single-dose diclofenac: potential for opioid-related toxicity","volume":"88","author":"Tighe","year":"1999","journal-title":"Anesth Analg"},{"key":"10.1124\/jpet.123.001651_bib219","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0022-3565(24)36505-X","article-title":"Effect of cytochrome P450 2D1 inhibition on hydrocodone metabolism and its behavioral consequences in rats","volume":"280","author":"Tomkins","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"2, Suppl","key":"10.1124\/jpet.123.001651_bib220","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.36076\/ppj.2008\/11\/S133","article-title":"Opioid pharmacology","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician"},{"key":"10.1124\/jpet.123.001651_bib221","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1124\/dmd.114.057000","article-title":"Relative contributions of cytochrome CYP3A4 versus CYP3A5 for CYP3A-cleared drugs assessed in vitro using a CYP3A4-selective inactivator (CYP3cide)","volume":"42","author":"Tseng","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.123.001651_bib222","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.pharmtox.40.1.581","article-title":"Human UDP-glucuronosyltransferases: metabolism, expression, and disease","volume":"40","author":"Tukey","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.123.001651_bib223","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2021.100442","article-title":"Inhibitory effects of non-steroidal anti-inflammatory drugs on human liver microsomal morphine glucuronidation: Implications for drug-drug interaction liability","volume":"42","author":"Uchaipichat","year":"2022","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/jpet.123.001651_bib224","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1038\/s41386-018-0225-3","article-title":"Untangling the complexity of opioid receptor function","volume":"43","author":"Valentino","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.123.001651_bib225","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jat\/bks058","article-title":"Excretion profile of hydrocodone, hydromorphone and norhydrocodone in urine following single dose administration of hydrocodone to healthy volunteers","volume":"36","author":"Valtier","year":"2012","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.123.001651_bib226","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0304-3959(90)91068-T","article-title":"Studies on the effects of antidepressant drugs on the antinociceptive action of morphine and on plasma morphine in rat and man","volume":"43","author":"Ventafridda","year":"1990","journal-title":"Pain"},{"key":"10.1124\/jpet.123.001651_bib227","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0773.1994.tb00319.x","article-title":"Tricyclic antidepressants inhibit opioid receptor binding in human brain and hepatic morphine glucuronidation","volume":"75","author":"Wahlstr\u00f6m","year":"1994","journal-title":"Pharmacol Toxicol"},{"key":"10.1124\/jpet.123.001651_bib228","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1476-5381.1988.tb11598.x","article-title":"Human liver morphine UDP-glucuronyl transferase enantioselectivity and inhibition by opioid congeners and oxazepam","volume":"94","author":"Wahlstr\u00f6m","year":"1988","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib229","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1369-1600.2011.00419.x","article-title":"Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers","volume":"18","author":"Walsh","year":"2013","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.123.001651_bib230","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00000542-200204000-00019","article-title":"Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein","volume":"96","author":"Wandel","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.123.001651_bib231","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/tpj.2010.28","article-title":"Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs","volume":"11","author":"Wang","year":"2011","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/jpet.123.001651_bib232","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2174\/1389200219666180307122945","article-title":"Regulation of Mammalian UDP-Glucuronosyltransferases","volume":"19","author":"Wang","year":"2018","journal-title":"Curr Drug Metab"},{"key":"10.1124\/jpet.123.001651_bib233","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.bcp.2011.08.004","article-title":"Characterizing the effect of UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofen","volume":"82","author":"Wang","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib234","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00228-017-2395-z","article-title":"Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis","volume":"74","author":"Wang","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib235","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/jps.2600680441","article-title":"Determination of oxycodone in plasma and identification of a major metabolite","volume":"68","author":"Weinstein","year":"1979","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.123.001651_bib236","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.clpt.2005.11.015","article-title":"Identification and characterization of CYP3A4*20, a novel rare CYP3A4 allele without functional activity","volume":"79","author":"Westlind-Johnsson","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.123.001651_bib237","doi-asserted-by":"crossref","first-page":"E348","DOI":"10.1007\/BF02854905","article-title":"Role of morphine\u2019s metabolites in analgesia: concepts and controversies","volume":"8","author":"Wittwer","year":"2006","journal-title":"AAPS J"},{"key":"10.1124\/jpet.123.001651_bib238","series-title":"WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents","article-title":"Table A6.2, Approximate potency of opioids relative to morphine; PO and immediate-release formulations unless stated otherwise","year":"2018"},{"key":"10.1124\/jpet.123.001651_bib239","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0024-3205(01)01133-X","article-title":"Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide","volume":"69","author":"Wright","year":"2001","journal-title":"Life Sci"},{"key":"10.1124\/jpet.123.001651_bib240","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/jps.2600660921","article-title":"Isolation and identification of morphine 3- and 6-glucuronides, morphine 3,6-diglucuronide, morphine 3-ethereal sulfate, normorphine, and normorphine 6-glucuronide as morphine metabolites in humans","volume":"66","author":"Yeh","year":"1977","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.123.001651_bib241","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1097\/j.pain.0000000000002291","article-title":"Prevalence of chronic pain among adults in the United States","volume":"163","author":"Yong","year":"2022","journal-title":"Pain"},{"key":"10.1124\/jpet.123.001651_bib243","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2125.1991.tb05586.x","article-title":"A comparison of the pharmacokinetics of codeine and its metabolites in healthy Chinese and Caucasian extensive hydroxylators of debrisoquine","volume":"31","author":"Yue","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib242","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2125.1991.tb05585.x","article-title":"Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine","volume":"31","author":"Yue","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001651_bib244","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.123.001651_bib245","first-page":"1","article-title":"Chronic Pain and High-impact Chronic Pain Among U.S. Adults, 2019","author":"Zelaya","year":"2020","journal-title":"NCHS Data Brief"},{"key":"10.1124\/jpet.123.001651_bib246","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/00498250110119090","article-title":"Hydromorphone metabolites: isolation and identification from pooled urine samples of a cancer patient","volume":"32","author":"Zheng","year":"2002","journal-title":"Xenobiotica"},{"key":"10.1124\/jpet.123.001651_bib247","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1016\/j.lfs.2004.06.008","article-title":"Identification and synthesis of norhydromorphone, and determination of antinociceptive activities in the rat formalin test","volume":"75","author":"Zheng","year":"2004","journal-title":"Life Sci"},{"key":"10.1124\/jpet.123.001651_bib248","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2165\/11318030-000000000-00000","article-title":"Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I","volume":"48","author":"Zhou","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.123.001651_bib249","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1742-7843.2009.00378.x","article-title":"The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism","volume":"104","author":"Zwisler","year":"2009","journal-title":"Basic Clin Pharmacol Toxicol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524171042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524171042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.123.001651","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T11:52:16Z","timestamp":1740657136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524171042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":252,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0022356524171042"],"URL":"https:\/\/doi.org\/10.1124\/jpet.123.001651","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrocodone, Oxycodone, and Morphine Metabolism and Drug\u2013Drug Interactions","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.123.001651","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The Author(s)","name":"copyright","label":"Copyright"}]}}